Physician profile
Don Minchen Schaffer
NPI 1336151521
$3,294.02
in general payments reported to CMS, 2019-2025
20 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $1,427 · 2021: $159 · 2022: $228 · 2023: $307 · 2024: $417 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,381.68 | 2019-2025 | |
| Corium, LLC | $511.89 | 2021-2025 | Azstarys |
| Sanofi Pasteur INC. | $369.55 | 2019-2025 | |
| Cranial Technologies, INC | $217.71 | 2019-2025 | Doc Band |
| Tris Pharma INC | $139.41 | 2023-2025 | Dyanavel Xr, Onyda Xr, Quillivant |
| Takeda Pharmaceuticals U.S.A., INC. | $122.83 | 2020-2023 | Vpriv |
| Merck Sharp & Dohme LLC | $119.51 | 2019-2023 | Gardasil 9, Vaxneuvance, Vaxelis |
| Ironshore Pharmaceuticals INC. | $92.24 | 2019-2022 | |
| Shire North American Group INC | $58.71 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $43.67 | 2019-2020 | |
| Genentech USA, INC. | $36.84 | 2020 | |
| Glaxosmithkline, LLC. | $32.16 | 2023-2025 | Bexsero, Pediarix |
| Sobi, INC | $30.82 | 2023 | |
| Supernus Pharmaceuticals, INC. | $29.44 | 2024 | Qelbree |
| Cipher Pharmaceuticals US LLC | $25.02 | 2025 | Natroba, Spinosad |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $22.08 | 2023 | Spinraza |
| Verrica Pharmaceuticals INC. | $18.42 | 2024 | Ycanth |
| Nestle Healthcare Nutrition INC. | $15.40 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.43 | 2019 | |
| Phadia US INC. | $13.21 | 2024 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Don Schaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.